CMR Imaging Techniques for Heart Disease
(Myomapping Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
CMR imaging is a powerful tool for diagnosing and monitoring heart diseases because it provides detailed images of the heart without using radiation. It is especially useful for evaluating conditions like coronary artery disease and cardiomyopathies, offering important information that other imaging methods cannot provide.
12345CMR imaging is generally considered safe as it is non-invasive and does not use radiation. However, there are some safety considerations, such as the presence of metal or electronic devices in the body, and potential discomfort from claustrophobia or the need to hold your breath during the procedure.
36789CMR imaging is unique because it provides a noninvasive way to assess the heart's structure and function, offering detailed tissue characterization and the ability to evaluate heart disease without the need for invasive procedures. Unlike other treatments, it can provide comprehensive diagnostic and prognostic information, making it a valuable tool for monitoring heart disease over time.
1241011Eligibility Criteria
This trial is for adults aged 18-90 with suspected or diagnosed heart conditions like ischemic heart disease, hypertrophic cardiomyopathy, infiltrative cardiomyopathy, or myocarditis. They must be referred for a CMR scan and can't participate if they have metal implants, acute psychiatric disorders, substance abuse issues, allergies to MRI contrast agents, are in an unstable condition or won't follow the study rules.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo fast quantitative myocardial tissue characterization using Cardiac Magnetic Resonance Imaging (CMR) techniques
Follow-up
Participants are monitored for safety and effectiveness after imaging